Provisional Patent Applications
RBI, Inc. is taking the necessary steps to bring our technique to the global medical market. Currently, we have applications and provisional applications for:
• Wnt-activated adipose-derived stem cell apparatuses, methods, and systems.
• Methods and apparatuses for instilling stem cells and pharmaceuticals into the human ventricular system.
Know-How
Our staff has the knowledge you would expect from seasoned biomedical researchers. This includes creating proprietary culture methods that support our work with therapies for neurodegenerative diseases.
The global center nervous system therapeutic market was worth USD 77.2 billion in 2016 and is anticipated to grow at a CAGR of 5.9%